全文获取类型
收费全文 | 424篇 |
免费 | 53篇 |
出版年
2022年 | 6篇 |
2021年 | 5篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 8篇 |
2016年 | 9篇 |
2015年 | 26篇 |
2014年 | 12篇 |
2013年 | 12篇 |
2012年 | 21篇 |
2011年 | 18篇 |
2010年 | 20篇 |
2009年 | 15篇 |
2008年 | 20篇 |
2007年 | 12篇 |
2006年 | 18篇 |
2005年 | 10篇 |
2004年 | 10篇 |
2003年 | 15篇 |
2002年 | 17篇 |
2001年 | 16篇 |
2000年 | 13篇 |
1999年 | 7篇 |
1998年 | 9篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1991年 | 6篇 |
1990年 | 10篇 |
1989年 | 10篇 |
1988年 | 8篇 |
1987年 | 5篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1974年 | 4篇 |
1973年 | 6篇 |
1972年 | 3篇 |
1970年 | 5篇 |
1969年 | 3篇 |
1945年 | 2篇 |
1922年 | 2篇 |
1905年 | 2篇 |
排序方式: 共有477条查询结果,搜索用时 343 毫秒
401.
Sorghum is a rich source of various phytochemicals including tannins, phenolic acids, anthocyanins, phytosterols and policosanols. These phytochemicals have potential to significantly impact human health. Sorghum fractions possess high antioxidant activity in vitro relative to other cereals or fruits. These fractions may offer similar health benefits commonly associated with fruits. Available epidemiological evidence suggests that sorghum consumption reduces the risk of certain types of cancer in humans compared to other cereals. The high concentration of phytochemicals in sorghum may be partly responsible. Sorghums containing tannins are widely reported to reduce caloric availability and hence weight gain in animals. This property is potentially useful in helping reduce obesity in humans. Sorghum phytochemicals also promote cardiovascular health in animals. Such properties have not been reported in humans and require investigation, since cardiovascular disease is currently the leading killer in the developed world. This paper reviews available information on sorghum phytochemicals, how the information relates to current phytonutrient research and how it has potential to combat common nutrition-related diseases including cancer, cardiovascular disease and obesity. 相似文献
402.
403.
404.
405.
Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis 总被引:10,自引:0,他引:10
406.
The class I and II major histocompatibility complex (MHC) genes are apparently subject to evolution by a birth-and-death process. The rate of gene turnover is much slower in the latter genes than in the former. In placental mammals, the class II region can be subdivided into different orthologous subregions or gene clusters (DR, DQ, DO, and DN), but the origins and evolutionary relationships of these gene clusters are not well established. Here we report the results of our study of the times of origin and evolutionary relationships of these gene clusters in mammals. Our analysis suggests that both class II alpha-chain and beta-chain gene clusters are shared by placental mammals and marsupials, but the gene clusters from nonmammalian species are paralogous to mammalian gene clusters. We estimated the times of divergence between gene clusters in placental mammals using the linearized tree and distance regression methods. Our results indicate that most gene clusters originated 170-200 million years (MY) ago, but that DO beta-chain genes diverged from the other beta-chain gene clusters approximately 210-260 MY ago. The phylogenetic trees for the alpha- and beta-chain genes were not congruent, suggesting that the evolutionary history of the class II gene clusters is more complex than previously thought. 相似文献
407.
There is a developmental increase in agonist-induced surfactant secretion in type II cells. The response to the P2Y(2) agonist UTP is negligible in early newborn cells but increases with age. The response to terbutaline, N-ethylcarboxyamidoadenosine (NECA), and ATP also increases with age. As glucocorticoids are known to accelerate several aspects of lung maturation we examined the effect of dexamethasone (Dex) on the response of 1-day-old rat type II cells to surfactant secretagogues. Freshly isolated cells were cultured +/-10(-6) M Dex for 18--20 h after which phosphatidylcholine secretion was measured. Dex slightly decreased the basal secretion rate. However, it significantly increased the response to terbutaline, NECA, ATP and UTP. This effect was dependent on Dex concentration (EC(50)=2-6 x 10(-9) M) and blocked by the glucocorticoid receptor antagonist RU-486. It is unlikely to be due to increased receptor content as Dex had no effect on adenylate cyclase, phospholipase C or phospholipase D activation and the response to cAMP, forskolin and phorbol ester, secretagogues acting downstream from receptors, was also increased by Dex. These data show that Dex acts directly on the type II cell to enhance the response to surfactant secretagogues, that the effect of the hormone is mediated by the glucocorticoid receptor and suggest induction of a common downstream signaling step(s). Regulation of surfactant secretion may be an important function of glucocorticoids in the developing lung. 相似文献
408.
409.
Rooney CI Rodrigues LC Campbell OM 《BMJ (Clinical research ed.)》2000,321(7263):760; author reply 761
410.
Paul Roepman Erica de Koning Dik van Leenen Roel A de Weger J Alain Kummer Piet J Slootweg Frank CP Holstege 《Genome biology》2007,7(12):R117